Analysis
DEEP FOCUS: Everything you need to know about Spotify (SPOT) stock
Spotify (NYSE: SPOT) stock has recovered 38% since late December when it touched a new 52-week low of...
ADVERTISEMENT
Analysis
Expert equity analysis, earnings previews, and data-driven market research.
Latest Research
2,307 articles
Analysis
Abbvie’s oncology push makes it an attractive stock
Abbvie (NYSE: ABBV) is one of the worse performing pharma stocks in the trailing 12-month period. The stock...
Analysis
Top biotech stocks to be considered for investment this year
When the massive selloff battered Wall Street in the final months of 2018, biotechnology stocks were no exception....
Analysis
Rating downgrade of Lam Research dampens recovery hopes; stock dips 4%
The recovery of Lam Research (LRCX) from last year’s lows had received a boost after the latest earnings...
Analysis
IPO: Things to know as Crowdstrike makes a scintillating market debut
You have probably heard about Crowdstrike already. It has previously unraveled a few high-profile hack incidents, including tracing...
Analysis
Top 5 tech M&A announcements so far in 2019
The technology sector is fast evolving with new start-ups offering innovative services popping up on a regular basis....
Analysis
Duluth Holdings to report loss in Q1 as margins remain under stress
Duluth Holdings (Nasdaq: DLTH), a retailer of casual wear and accessories, will be publishing financial results for the...
Analysis
LightPath Technologies stock dips to 4-year low
LightPath Technologies (NASDAQ: LPTH) stock fell to a 4-year low of $0.94 on Monday as investors remained concerned...
Analysis
These deals set a new paradigm for healthcare industry
After a busy 2018, the scale of merger and acquisition activity in the healthcare industry is expected to...
Analysis
Facebook – Will the giant fall or not?
Facebook (NYSE: FB) is in the middle of a storm right now with anti-trust probes and even calls...
Analysis
CorVel stock soars to all-time high, but trading remains tepid
CorVel Corporation (NASDAQ: CRVL) stock soared to a 28-year high of $78.70 on Thursday as the shares are...
Analysis
What’s in store for top pharma stocks this year
The stocks of leading pharmaceutical firms shifted to growth mode this year after winding up 2018 on a...